Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1978 ARTÍCULOS , VIENDO DEL 661 AL 675
Ferulic Acid in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies
Wang EJ, Wu MY, Lu JH.
Cells. 2021 Oct 5;10(10):2653. doi: 10.3390/cells10102653.
The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer's Disease
Ogunmokun G, Dewanjee S, Chakraborty P, Valupadas C, Chaudhary A, Kolli V, Anand U, Vallamkondu J, Goel P, Paluru HPR, Gill KD, Reddy PH, De Feo V, Kandimalla R.
Cells. 2021 Oct 18;10(10):2790. doi: 10.3390/cells10102790.
A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials
Gonzales MM, Krishnamurthy S, Garbarino V, Daeihagh AS, Gillispie GJ, Deep G, Craft S, Orr ME.
Mech Ageing Dev. 2021 Dec;200:111589. doi: 10.1016/j.mad.2021.111589. Epub 2021 Oct 21.
FDA Drug Approval and the Ethics of Desperation
Largent EA, Peterson A, Lynch HF.
JAMA Intern Med. 2021 Dec 1;181(12):1555-1556. doi: 10.1001/jamainternmed.2021.6045.
A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer's Disease
Arora S, Sharma D, Layek B, Singh J.
Mol Pharm. 2021 Dec 6;18(12):4237-4255. doi: 10.1021/acs.molpharmaceut.1c00611. Epub 2021 Oct 27.
Genomics of Alzheimer's disease implicates the innate and adaptive immune systems
Li Y, Laws SM, Miles LA, Wiley JS, Huang X, Masters CL, Gu BJ.
Cell Mol Life Sci. 2021 Dec;78(23):7397-7426. doi: 10.1007/s00018-021-03986-5. Epub 2021 Oct 27.
Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease
Liu H, Zhou YC, Song W.
Int Immunopharmacol. 2021 Dec;101(Pt A):108263. doi: 10.1016/j.intimp.2021.108263. Epub 2021 Oct 29.
To target Tau pathologies, we must embrace and reconstruct their complexities
Limorenko G, Lashuel HA.
Neurobiol Dis. 2021 Dec;161:105536. doi: 10.1016/j.nbd.2021.105536. Epub 2021 Oct 27.
Nanomaterials in Alzheimer's disease treatment: a comprehensive review
Faiyaz M, Ganayee MA, Akhtar S, Krishnan S, Flora B, Dogra D, Jha NK, Chellappan DK, Negi P, Dua K, Kesari KK, Gupta PK.
Front Biosci (Landmark Ed). 2021 Oct 30;26(10):851-865. doi: 10.52586/4992.
Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease
Schultz B, Taday J, Menezes L, Cigerce A, Leite MC, Gonçalves CA.
J Alzheimers Dis. 2021;84(4):1415-1430. doi: 10.3233/JAD-215182.
Artificial Chiral Interfaces against Amyloid-β Peptide Aggregation: Research Progress and Challenges
Zhou Z, Gu YQ, Wang HX.
ACS Chem Neurosci. 2021 Nov 17;12(22):4236-4248. doi: 10.1021/acschemneuro.1c00544. Epub 2021 Nov 1.
Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease
Padmanabhan P, Kneynsberg A, Götz J.
Nat Rev Neurosci. 2021 Dec;22(12):723-740. doi: 10.1038/s41583-021-00531-y. Epub 2021 Nov 1.
Feng YY, Chen H.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021 Oct;43(5):788-795. doi: 10.3881/j.issn.1000-503X.12585.
Randhawa S, Abidi SMS, Dar AI, Acharya A.
Int J Biol Macromol. 2021 Dec 15;193(Pt A):1009-1020. doi: 10.1016/j.ijbiomac.2021.10.195. Epub 2021 Oct 30.
Un nouveau traitement pour la maladie d’Alzheimer ? Espoirs et controverses
Gold G, Büla C.
Rev Med Suisse. 2021 Nov 3;17(757):1863-1864.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.